GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Gastroenterologist Dr. Rohan Mandaliya of The Center for Comprehensive Pancreatic Care at Mercy goes over the risk factors of ...

Symptoms of pancreatic cancer can be difficult to spot, but the sooner the patient is diagnosed the better prospects they ...

The two companies have been conducting combination therapy study of the immuno-oncology drug GI-102 and ADC LM-302 targeting Claudin18.2 and recently observed excellent anticancer activity in a ...

Like any other organ, the pancreas can develop tumours. However, not all tumours are cancerous, and pancreatic cancer has an aggressive nature and late diagnosis. Pancreatic cancer may be less ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...